Cited by 662Alzheimer's disease research and treatmentsDrug Transport and Resistance MechanismsBarrier Structure and Function Studies

The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.

P-glycoprotein deficiency at the blood-brain barrier increases amyloid- deposition in an Alzheimer disease mouse model

Open access

Cirrito, J. R.·2005·Journal of Clinical Investigation

DOI 10.1172/jci25247PMC PMC1257538

Open this paper in CoChat — free account Open PDF

Abstract

Accumulation of amyloid-beta (Abeta) within extracellular spaces of the brain is a hallmark of Alzheimer disease (AD). In sporadic, late-onset AD, there is little evidence for increased Abeta production, suggesting that decreased elimination from the brain may contribute to elevated levels of Abeta and plaque formation. Efflux transport of Abeta across the blood-brain barrier (BBB) contributes to Abeta removal from the brain. P-glycoprotein (Pgp) is highly expressed on the luminal surface of brain capillary endothelial cells and contributes to the BBB. In Pgp-null mice, we show that [I]Abeta40 and [I]Abeta42 microinjected into the CNS clear at half the rate that they do in WT mice. When amyloid precursor protein-transgenic (APP-transgenic) mice were administered a Pgp inhibitor, Abeta levels within the brain interstitial fluid significantly increased within hours of treatment. Furthermore, APP-transgenic, Pgp-null mice had increased levels of brain Abeta and enhanced Abeta deposition compared with APP-transgenic, Pgp WT mice. These data establish a direct link between Pgp and Abeta metabolism in vivo and suggest that Pgp activity at the BBB could affect risk for developing AD as well as provide a novel diagnostic and therapeutic target.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci25247

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H., Brockmöller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M. F., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3473 · Cited by 2,366
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
Schinkel, A. H., Smit, J., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., Riele, H. T., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,284
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I. H., & Gottesman, M. M. (1999) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.361 · Cited by 2,059
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,526
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426
Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance
Marzolini, C. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.09.012 · Cited by 907
Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830

Show all 34 references

Sorted by citations

Items 301–400 of 662

Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer’s Disease
Petralla, S., Panayotova, M., Franchina, E., Fricker, G., & Puris, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070948 · Cited by 46
From the Cover: Comparative Proteomics Reveals Silver Nanoparticles Alter Fatty Acid Metabolism and Amyloid Beta Clearance for Neuronal Apoptosis in a Triple Cell Coculture Model of the Blood–Brain Barrier
Lin, H.-C., Ho, M., Tsen, C.-M., Huang, C.-C., Wu, C.-C., Huang, Y.-J., Hsiao, I., & Chuang, C. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx079 · Cited by 43
Advanced Human BBB‐on‐a‐Chip: A New Platform for Alzheimer's Disease Studies
Yoon, J., Kim, J., Shah, Z., Awasthi, A., Mahajan, A., & Kim, Y. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002285 · Cited by 45
Stimulation of the Retinoid X Receptor Facilitates Beta-Amyloid Clearance Across the Blood–Brain Barrier
Bachmeier, C., Beaulieu-Abdelahad, D., Crawford, F., Mullan, M., & Paris, D. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9866-6 · Cited by 39
Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer’s disease
Madadi, S., Schwarzenbach, H., Saidijam, M., Mahjub, R., & Soleimani, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0354-3 · Cited by 41
Blood-brain barrier transport of amyloid beta peptides in efflux pump knock-out animals evaluated by in vivo optical imaging
Zhang, W., Xiong, H., Callaghan, D., Liu, H., Jones, A., Pei, K., Fatehi, D., Brunette, E., & Stanimirovic, D. B. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-13 · Cited by 43
Association of ATP-Binding Cassette Transporter Variants With the Risk of Alzheimer‘s Disease
Cascorbi, I., Flüh, C., Remmler, C., Haenisch, S., Faltraco, F., Grumbt, M., Peters, M., Brenn, A., Thal, D. R., Warzok, R., et al. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.18 · Cited by 41
A Promising Approach: Magnetic Nanosystems for Alzheimer’s Disease Theranostics
Chaparro, C. I. P., Simões, B. T., Borges, J. P., Castanho, M. A. R. B., Soares, P. I. P., & Neves, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092316 · Cited by 40
Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen
Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie · doi:10.1002/ange.200802808 · Cited by 41
Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs
Shen, Y., Zhao, M., Zhao, P., Meng, L., Zhang, Y., Zhang, G., Taishi, Y., & Sun, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1408462 · Cited by 45
Juvenile Traumatic Brain Injury Induces Long-Term Perivascular Matrix Changes Alongside Amyloid-Beta Accumulation
Jullienne, A., Roberts, J., Pop, V., Murphy, M. P., Head, E., Bix, G. J., & Badaut, J. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.124 · Cited by 42
Metals and cholesterol: two sides of the same coin in Alzheimer’s disease pathology
Wong, B. X. W., Hung, Y. H., Bush, A. I., & Duce, J. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00091 · Cited by 41
PPARγ agonists regulate bidirectional transport of amyloid‐β across the blood–brain barrier and hippocampus plasticity in db/db mice
Wang, H., Chen, F., Zhong, K. L., Tang, S. S., Hu, M. Y., Long, Y., Miao, M. X., Liao, J. M., Sun, H. B., & Hong, H. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13378 · Cited by 38
Can insulin signaling pathways be targeted to transport Aβ out of the brain?
Vandal, M., Bourassa, P., & Calon, F. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00114 · Cited by 37
Opposing effects ofApoe/Apoa1double deletion on amyloid-β pathology and cognitive performance in APP mice
Fitz, N. F., Tapias, V., Cronican, A. A., Castranio, E. L., Saleem, M., Carter, A. Y., Lefterova, M. I., Lefterov, I. M., & Koldamova, R. P. (2015) · Brain · doi:10.1093/brain/awv293 · Cited by 38
Alzheimer's Disease—Current Status and Future Directions
Bhardwaj, D., Mitra, C., Narasimhulu, C. A., Riad, A., Doomra, M., & Parthasarathy, S. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2017.0093 · Cited by 37
Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317
Eckert, G. P., Vardanian, L., Rebeck, G. W., & Burns, M. P. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.05.063 · Cited by 39
MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease
Ban, J.-J., Chung, J.-Y., Lee, M., Im, W., & Kim, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.040 · Cited by 36
Streptococcus agalactiae disrupts P-glycoprotein function in brain endothelial cells
Kim, B. J., McDonagh, M. A., Deng, L., Gastfriend, B. D., Schubert‐Unkmeir, A., Doran, K. S., & Shusta, E. V. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0146-5 · Cited by 35
New drugs from ancient natural foods. Oleocanthal, the natural occurring spicy compound of olive oil: a brief history
Scotece, M., Conde, J., Abella, V., Lopez, V., Pino, J., Lago, F., Smith, A. B., Gómez-Reino, J. J., & Gualillo, O. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.017 · Cited by 36
Functional Expression of Drug Transporters in Glial Cells
Ashraf, T., Kao, A. C.-C., & Bendayan, R. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.010 · Cited by 38
Peripheral elevation of IGF-1 fails to alter Aβ clearance in multiple in vivo models
Lanz, T. A., Salatto, C. T., Semproni, A. R., Marconi, M., Brown, T. M., Richter, K. E. G., Schmidt, K., Nelson, F. R., & Schachter, J. B. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.11.001 · Cited by 37
Role of the transcription factor NRF2 in maintaining the integrity of the Blood-Brain Barrier
Cazalla, E., Cuadrado, A., & García‐Yagüe, Á. J. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00599-5 · Cited by 36
P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET Study
Savolainen, H., Meerlo, P., Elsinga, P. H., Windhorst, A. D., Dierckx, R., Colabufo, N. A., van Waarde, A., & Luurtsema, G. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9973-3 · Cited by 34
Kororamides, Convolutamines, and Indole Derivatives as Possible Tau and Dual-Specificity Kinase Inhibitors for Alzheimer’s Disease: A Computational Study
Llorach-Parés, L., Nonell‐Canals, A., Àvila, C., & Sánchez-Martínez, M. (2018) · Marine Drugs · doi:10.3390/md16100386 · Cited by 35
Protecting P-glycoprotein at the blood–brain barrier from degradation in an Alzheimer’s disease mouse model
Ding, Y., Zhong, Y., Baldeshwiler, A., Abner, E. L., Bauer, B., & Hartz, A. M. S. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00245-4 · Cited by 35
Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration
Hsu, M., Sheu, J., Lin, C., Shen, M., & Hsu, C. Y. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.08.003 · Cited by 34
A Generator-Produced Gallium-68 Radiopharmaceutical for PET Imaging of Myocardial Perfusion
Sharma, V., Sivapackiam, J., Harpstrite, S. E., Prior, J. L., Gu, H., Rath, N. P., & Piwnica-Worms, D. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109361 · Cited by 34
Synthesis, Molecular Modeling, and Evaluation of Novel Sulfonylhydrazones as Acetylcholinesterase Inhibitors for Alzheimer's Disease
Fernandes, T. B., Cunha, M. R., Sakata, R. P., Cândido, T. M., Baby, A. R., Tavares, M. T., Barbosa, E. G., Almeida, W. P., & Parise‐Filho, R. (2017) · Archiv der Pharmazie · doi:10.1002/ardp.201700163 · Cited by 33
Involvement of Insulin-Degrading Enzyme in Insulin- and Atrial Natriuretic Peptide-Sensitive Internalization of Amyloid-β Peptide in Mouse Brain Capillary Endothelial Cells
Ito, S., Ohtsuki, S., Murata, S., Katsukura, Y., Suzuki, H., Funaki, M., Tachikawa, M., & Terasaki, T. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122077 · Cited by 34
P-gp Transporter and its Role in Neurodegenerative Diseases
Rapposelli, S., Digiacomo, M., & Balsamo, A. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609787521544 · Cited by 37
Age-related decline in blood-brain barrier function is more pronounced in males than females in parietal and temporal regions
Shao, X., Shou, Q., Felix, K., Ojogho, B., Jiang, X., Gold, B. T., Herting, M. M., Goldwaser, E. L., Kochunov, P., Hong, E. L., et al. (2024) · eLife · doi:10.7554/elife.96155.3 · Cited by 50
Isolation of Cerebral Capillaries from Fresh Human Brain Tissue
Hartz, A. M. S., Schulz, J., Sokola, B. S., Edelmann, S. E., Shen, A. N., Rempe, R. G., Zhong, Y., Seblani, N. E., & Bauer, B. (2018) · Journal of Visualized Experiments · doi:10.3791/57346 · Cited by 33
The Blood-Brain Barrier in Alzheimer’s Disease
Storck, S. E., Hartz, A. M. S., & Pietrzik, C. U. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_418 · Cited by 31
From cradle to grave: neurogenesis, neuroregeneration and neurodegeneration in Alzheimer’s and Parkinson’s diseases
Wakhloo, D., Mahajani, S. U., Oberhauser, J., & Madira, A. E. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.336138 · Cited by 38
The multidrug resistance pump ABCB1 is a substrate for the ubiquitin ligase NEDD4-1
Akkaya, B. G., Zolnerciks, J. K., Ritchie, T. K., Bauer, B., Hartz, A. M. S., Sullivan, J. A., & Linton, K. J. (2015) · Molecular Membrane Biology · doi:10.3109/09687688.2015.1023378 · Cited by 33
Tissue-Plasminogen Activator Attenuates Alzheimer’s Disease-Related Pathology Development in APPswe/PS1 Mice
ElAli, A., Bordeleau, M., Thériault, P., Filali, M., Lampron, A., & Rivest, S. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.279 · Cited by 32
Synthesis, and the antioxidant, neuroprotective and P-glycoprotein induction activity of 4-arylquinoline-2-carboxylates
Bharate, J. B., Wani, A., Sharma, S., Reja, S. I., Kumar, M., Vishwakarma, R. A., Kumar, A., & Bharate, S. B. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob00488d · Cited by 32
Impaired mitochondrial energy production and ABC transporter function—A crucial interconnection in dementing proteopathies of the brain
Pahnke, J., Fröhlich, C., Krohn, M., Schumacher, T., & Paarmann, K. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.08.007 · Cited by 35
Verapamil and Alzheimer’s Disease: Past, Present, and Future
Popović, N., Morales-Delgado, N., Mena, D. V., Alonso, A., Martínez, M. P., Bleda, M. C., & Popović, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00562 · Cited by 34
Dickkopf-related protein-1 inhibition attenuates amyloid-beta pathology associated to Alzheimer's disease
Menet, R., Bourassa, P., Calon, F., & ElAli, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104881 · Cited by 31
An Appraisal of the Oleocanthal-Rich Extra Virgin Olive Oil (EVOO) and Its Potential Anticancer and Neuroprotective Properties
Infante, R., Infante, M., Pastore, D., Pacifici, F., Chiereghin, F., Malatesta, G., Donadel, G., Tesauro, M., & Della‐Morte, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417323 · Cited by 38
Metabolite Clearance During Wakefulness and Sleep
Hladky, S. B., & Barrand, M. A. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_37 · Cited by 36
Senescence-associated microvascular endothelial dysfunction: A focus on the blood-brain and blood-retinal barriers
Kim, S. Y., & Cheon, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102446 · Cited by 33
An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter
Kannan, P., Schain, M., Kretzschmar, W. W., Weidner, L. D., Mitsios, N., Gulyás, B. Z., Blom, H., Gottesman, M. M., Innis, R. B., Hall, M. D., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16660984 · Cited by 32
ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology
Cao, Y., Xu, H., Zhu, Y., Shi, M.-J., Wei, L., Zhang, J., Cheng, S., Shi, Y., Tong, H., Kang, L., et al. (2019) · PLOS Biology · doi:10.1371/journal.pbio.3000313 · Cited by 31
Retracted
Cerebral ABC Transporter-common Mechanisms May Modulate Neurodegenerative Diseases and Depression in Elderly Subjects
Pahnke, J., Fröhlich, C., Paarmann, K., Krohn, M., Bogdanović, N., Årsland, D., & Winblad, B. G. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.10.010 · Cited by 30
Roflumilast ameliorates cognitive deficits in a mouse model of amyloidogenesis and tauopathy: Involvement of nitric oxide status, Aβ extrusion transporter ABCB1, and reversal by PKA inhibitor H89
Ashour, N. H., El-Tanbouly, D. M., Sayed, N. S. E., & Khattab, M. M. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110366 · Cited by 30
Pediatric Traumatic Brain Injury: An Update on Preclinical Models, Clinical Biomarkers, and the Implications of Cerebrovascular Dysfunction
Nwafor, D. C., Brichacek, A. L., Foster, C. H., Lucke-Wold, B. P., Ali, A., Colantonio, M. A., Brown, C. M., & Qaiser, R. A. (2022) · Journal of Central Nervous System Disease · doi:10.1177/11795735221098125 · Cited by 31
Clinical Significance of Lipid Transport Function of ABC Transporters in the Innate Immune System
Kotlyarov, S. N., & Котлярова, А. А. (2022) · Membranes · doi:10.3390/membranes12111083 · Cited by 31
Nanomedicine based strategies for oligonucleotide traversion across the blood–brain barrier
Amulya, E., Sikder, A., Vambhurkar, G. B., Shah, S., Khatri, D. K., Raghuvanshi, R. S., Singh, S. B., & Srivastava, S. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.031 · Cited by 30
La barrière hémato-encéphalique
Gosselet, F., Candela, P., Cecchelli, R., & Fénart, L. (2011) · médecine/sciences · doi:10.1051/medsci/20112711015 · Cited by 42
Modulation of Alzheimer’s disease brain pathology in mice by gut bacterial depletion: the role of IL-17a
Hao, W., Luo, Q., Tomic, I., Quan, W., Hartmann, T., Menger, M. D., Fassbender, K. C., & Liu, Y. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2363014 · Cited by 29
Protection of the Blood-Brain Barrier by Pentosan Against Amyloid-β-Induced Toxicity
Deli, M. A., Veszelka, S., Csiszár, B., Tóth, A. E., Kittel, Á., Csete, M., Sipos, Á., Szalai, A., Fülöp, L., Penke, B., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100759 · Cited by 30
Age-dependent decline of blood–brain barrier P-glycoprotein expression in the canine brain
Pekcec, A., Schneider, E. L., Baumgärtner, W., Stein, V. M., Tipold, A., & Potschka, H. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.014 · Cited by 29
Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice
Tóth, M. E., Dukay, B., Hoyk, Z., & Sántha, M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200218101818 · Cited by 32
Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta
Taggi, V., Riera‐Romo, M., Piquette‐Miller, M., zu Schwabedissen, H. E. M., & Neuhoff, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071376 · Cited by 30
Blood–brain borders: a proposal to address limitations of historical blood–brain barrier terminology
Badaut, J., Ghersi‐Egea, J., Thorne, R. G., & Konsman, J. P. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00478-5 · Cited by 31
Vascular impairment as a pathological mechanism underlying long-lasting cognitive dysfunction after pediatric traumatic brain injury
Ichkova, A., Rodriguez‐Grande, B., Bar, C., Villega, F., Konsman, J. P., & Badaut, J. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.022 · Cited by 29
In Vitro Investigation of Amyloid-β Hepatobiliary Disposition in Sandwich-Cultured Primary Rat Hepatocytes
Mohamed, L. A., & Kaddoumi, A. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052514 · Cited by 29
Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model
Vulin, M., Zhong, Y., Maloney, B. J., Bauer, B., & Hartz, A. M. S. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00470-z · Cited by 28
Evaluation of intracellular trafficking and clearance from HeLa cells of doxorubicin-bound block copolymers
Sakai‐Kato, K., Ishikura, K., Oshima, Y., Tada, M., Suzuki, T., Ishii‐Watabe, A., Yamaguchi, T., Nishiyama, N., Kataoka, K., Kawanishi, T., et al. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.022 · Cited by 28
Oxidation of KCNB1 channels in the human brain and in mouse model of Alzheimer’s disease
Yu, W., Shin, M. R., & Sesti, F. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0886-1 · Cited by 28
Expression of amyloid beta peptide in human platelets: Pivotal role of the phospholipase Cγ2-protein kinase C pathway in platelet activation
Shen, M., Hsiao, G., Fong, T., Chou, D., & Sheu, J. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.01.004 · Cited by 28
Effect of Structural Modifications to Glyoxal-bis(thiosemicarbazonato)copper(II) Complexes on Cellular Copper Uptake, Copper-Mediated ATP7A Trafficking, and P-Glycoprotein Mediated Efflux
Acevedo, K. M., Hayne, D. J., McInnes, L. E., Noor, A., Duncan, C., Moujalled, D., Volitakis, I., Rigopoulos, A., Barnham, K. J., Villemagne, V. L., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01158 · Cited by 27
Measurement of cerebral ABCC1 transport activity in wild-type and APP/PS1-21 mice with positron emission tomography
Zoufal, V., Mairinger, S., Krohn, M., Wanek, T., Filip, T., Sauberer, M., Stanek, J., Kuntner, C., Pahnke, J., & Langer, O. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19854541 · Cited by 26
Effect of Insulin Receptor-Knockdown on the Expression Levels of Blood–Brain Barrier Functional Proteins in Human Brain Microvascular Endothelial Cells
Nagano, H., Ito, S., Masuda, T., & Ohtsuki, S. (2021) · Pharmaceutical Research · doi:10.1007/s11095-021-03131-8 · Cited by 28
Effect of retinoic acid on the neurovascular unit: A review
Pouso, M. R., & Cairrão, E. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.03.011 · Cited by 27
Physicochemistry shapes bioactivity landscape of pan-ABC transporter modulators: Anchor point for innovative Alzheimer's disease therapeutics
Namasivayam, V., Stefan, K., Górecki, L., Korábečný, J., Soukup, O., Jansson, P. J., Pahnke, J., & Stefan, S. M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.07.062 · Cited by 27
The expression of P‐glycoprotein is increased in vessels with blood‐brain barrier impairment in a stroke‐prone hypertensive model
Ueno, M., Nakagawa, T., Huang, C. ‐., Ueki, M., Kusaka, T., Hosomi, N., Kanenishi, K., Onodera, M., Wu, B., & Sakamoto, H. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00966.x · Cited by 27
Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier
Mohamed, L. A., Zhu, H., Mousa, Y. M., Wang, E., Qiu, W. Q., & Kaddoumi, A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160800 · Cited by 27
Endothelial mitochondria in the blood-brain barrier
Shao, Y., Mai, L., Qiao, R., Liang, Y., Jiao, Y., Homburg, J., Jiang, Z., & Song, L. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00699-w · Cited by 29
Cerebrovascular Pathology in Hypertriglyceridemic APOB-100 Transgenic Mice
Hoyk, Z., Tóth, M. E., Lénárt, N., Nagy, D., Dukay, B., Csefová, A., Zvara, Á., Seprényi, G., Kincses, A., Walter, F. R., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00380 · Cited by 28
Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice
Abdallah, I. M., Al-Shami, K. M., Yang, E., & Kaddoumi, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031231 · Cited by 26
The Role of Clusterin Transporter in the Pathogenesis of Alzheimer’s Disease at the Blood–Brain Barrier Interface: A Systematic Review
Fareed, M. M., Qasmi, M., Aziz, S., Völker, E., Förster, C. Y., & Shityakov, S. (2022) · Biomolecules · doi:10.3390/biom12101452 · Cited by 25
Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease
Susmitha, G., & Kumar, R. K. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109478 · Cited by 27
Lack of Interactions Between an Antisense Oligonucleotide with 2′- O -(2-Methoxyethyl) Modifications and Major Drug Transporters
Yu, R. Z., Warren, M. S., Watanabe, T. A., Nichols, B., Jahic, M., Huang, J., Burkey, J., Geary, R. S., Henry, S. P., & Wang, Y. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0588 · Cited by 26
Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET
Zoufal, V., Wanek, T., Krohn, M., Mairinger, S., Filip, T., Sauberer, M., Stanek, J., Pekar, T., Bauer, M., Pahnke, J., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18806640 · Cited by 26
ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis
Jablonski, M., Miller, D. S., Pasinelli, P., & Trotti, D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.08.060 · Cited by 25
Astrocytic transporters in Alzheimer's disease
Ugbode, C., Hu, Y., Whalley, B., Peers, C., Rattray, M., & Dallas, M. L. (2017) · Biochemical Journal · doi:10.1042/bcj20160505 · Cited by 25
Endoplasmic Reticulum Malfunction in the Nervous System
Jung, J., Michalak, M., & Agellon, L. B. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00220 · Cited by 25
Endothelin-1 Reduces P-Glycoprotein Transport Activity in an In Vitro Model of Human Adult Blood–brain Barrier
Hembury, A., & Mabondzo, A. M. (2008) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-008-9277-y · Cited by 24
Mechanisms behind changes of neurodegeneration biomarkers in plasma induced by sleep deprivation
Eide, P. K., Lashkarivand, A., Pripp, A. H., Valnes, L. M., Hovd, M. H., Ringstad, G. A., Blennow, K., & Zetterberg, H. (2023) · Brain Communications · doi:10.1093/braincomms/fcad343 · Cited by 27
Meridianins and Lignarenone B as Potential GSK3β Inhibitors and Inductors of Structural Neuronal Plasticity
Llorach-Parés, L., Rodríguez-Urgellés, E., Nonell‐Canals, A., Alberch, J., Àvila, C., Sánchez-Martínez, M., & Giralt, A. (2020) · Biomolecules · doi:10.3390/biom10040639 · Cited by 24
Metalloprobes: Synthesis, characterization, and potency of a novel gallium(III) complex in human epidermal carcinoma cells
Harpstrite, S. E., Prior, J. L., Rath, N. P., & Sharma, V. (2007) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.04.013 · Cited by 24
The potential value of capsaicin in modulating cognitive functions in a rat model of streptozotocin-induced Alzheimer’s disease
Shalaby, M. A., Nounou, H. A., & Deif, M. M. (2019) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-019-0094-7 · Cited by 24
Copper bis(thiosemicarbazone) complexes modulate P‐glycoprotein expression and function in human brain microvascular endothelial cells
Pyun, J., McInnes, L. E., Donnelly, P. S., Mawal, C., Bush, A. I., Short, J. L., & Nicolazzo, J. A. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15609 · Cited by 23
Comparison of Oleocanthal-Low EVOO and Oleocanthal against Amyloid-β and Related Pathology in a Mouse Model of Alzheimer’s Disease
Abdallah, I. M., Al-Shami, K. M., Alkhalifa, A. E., Al-Ghraiybah, N. F., Guillaume, C., & Kaddoumi, A. (2023) · Molecules · doi:10.3390/molecules28031249 · Cited by 27
MDR1–P-glycoprotein (ABCB1)-Mediated Disposition of Amyloid-β Peptides: Implications for the Pathogenesis and Therapy of Alzheimer’s Disease
Jedlitschky, G., Vogelgesang, S., & Kroemer, H. K. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.126 · Cited by 23
Blood brain barrier-on-a-chip to model neurological diseases
Reshma, S. C., Megha, K. B., Amir, S., Rukhiya, S., & Mohanan, P. V. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104174 · Cited by 23
Peripheral inflammation is a potential etiological factor in Alzheimer’s disease
Li, Z., Wang, H., & Yin, Y. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2023-0049 · Cited by 23
Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington’s disease R6/2 model
Im, W., Ban, J., Chung, J. Y., Lee, S., Chu, K., & Kim, M. (2015) · Scientific Reports · doi:10.1038/srep16887 · Cited by 21
Contributions of Drug Transporters to Blood-Brain Barriers
Liu, L., & Liu, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_9 · Cited by 21
Astrocyte Clocks and Glucose Homeostasis
Barca‐Mayo, O., & López, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.662017 · Cited by 23
Astrocytes and human artificial blood-brain barrier models
Zidarič, T., Gradišnik, L., & Velnar, T. (2022) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2021.6943 · Cited by 23
Vascular endothelial cells: a fundamental approach for brain waste clearance
Wei, H., Jiang, H., Zhou, Y., Xiao, X., Zhou, C., & Ji, X. (2022) · Brain · doi:10.1093/brain/awac495 · Cited by 20
Proteomic alterations in the brain and blood–brain barrier during brain Aβ accumulation in an APP knock-in mouse model of Alzheimer’s disease
Ito, S., Yagi, R., Ogata, S., Masuda, T., Saito, T., Saido, T. C., & Ohtsuki, S. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00466-9 · Cited by 20
Synthesis, molecular structure, and validation of metalloprobes for assessment of MDR1 P-glycoprotein-mediated functional transport
Sivapackiam, J., Harpstrite, S. E., Prior, J. L., Gu, H., Rath, N. P., & Sharma, V. (2010) · Dalton Transactions · doi:10.1039/c002361b · Cited by 21
Insulin resistance: an emerging link in Alzheimer’s disease
Medhi, B., & Chakrabarty, M. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1454-1 · Cited by 23
Pregnane X Receptor and P-glycoprotein: a connexion for Alzheimer’s disease management
Jain, S. K., Rathod, V. P., Prajapati, R., Nandekar, P. P., & Sangamwar, A. T. (2014) · Molecular Diversity · doi:10.1007/s11030-014-9550-6 · Cited by 21

Authors: Cirrito, J. R.
Affiliations: Washington University in St. Louis (US)
Corresponding author: Cirrito, J. R.
ORCID: Cirrito, J. R.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2005-11-01
Volume: 115
Issue: 11
Pages: 3285-3290
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci25247
PMC: PMC1257538
OpenAlex: W2163209521
Cited by: 660
References: 34
Citations by year: 2026: 21 · 2025: 24 · 2024: 29 · 2023: 36 · 2022: 31 · 2021: 30 · 2020: 37 · 2019: 31 · 2018: 30 · 2017: 35 · 2016: 43 · 2015: 40 · 2014: 41 · 2013: 44 · 2012: 26
FWCI: 12.44
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
Funders: U.S. Department of Energy
National Institutes of Health (CA94056, AG13956)
National Institute on Aging (AG023316, R03AG023316, R01AG023084, AG23084, R01AG013956, R37AG023084, R37AG013956)
National Cancer Institute (P50 CA94056, P50CA094056)
National Institute of Allergy and Infectious Diseases (AI-13956)
National Institute of Neurological Disorders and Stroke (NS034467, R37NS034467, R01NS034467)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords: P-glycoprotein, blood-brain barrier, amyloid-beta, Alzheimer's disease, APP transgenic mice, P-glycoprotein inhibitors, brain interstitial fluid, amyloid-beta clearance, brain microvascular endothelial cells, amyloid-beta deposition
MeSH terms: Alzheimer Disease, Animals, Blood-Brain Barrier, Disease Models, Animal, Mice, Inbred C57BL, Mice, Transgenic, Polymorphism, Genetic, Up-Regulation, Amyloid beta-Peptides, Mice, Knockout, ATP Binding Cassette Transporter, Subfamily B, Member 1, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

P-glycoprotein deficiency at the blood-brain barrier increases amyloid- deposition in an Alzheimer disease mouse model

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks